期刊文献+

塞来昔布对四肢骨折急诊手术患者的镇痛作用分析 被引量:1

Perioperative celecoxib administration in pain management of limbs fracture surgery
下载PDF
导出
摘要 目的观察四肢骨折急诊手术患者围手术期使用塞来昔布的镇痛效果。方法 290例患者分为三组,A组100例,在手术前口服塞来昔布400mg,术后当天口服200mg,手术后第1-5天,口服200mg/次,每日2次;B组90例,术后当天口服200mg,手术后第1-5天,口服200mg/次,每日2次;B组100例,不服用塞来昔布,两组在手术后均不限制使用静脉止痛泵、肌注阿片类药物。观察两组术后疼痛的VAS评分、阿片类药物的用量以及呕吐情况。结果 A组在术后当天、术后第1天、第2天手术切口疼痛的VAS评分低于B、C组,差异有显著性(P〈0.05);术后第3天-第5天,手术切口疼痛的VAS评分相比无显著性差异。在术后当天至术后第5天内,A组使用哌替啶的次数少于B、C组(P〈0.05);出现呕吐的次数也低于对照组(P〈0.05)。结论在四肢骨折急诊手术患者的围手术期使用塞来昔布对患者有良好的镇痛效果,可减少术后阿片类药物的使用,减少术后呕吐反应,且超前镇痛仍有适用的意义。 Objective To evaluate the effects of perioperative celecoxib administration in pain management of patients undergoing limbs fracture surgery.Methods 290 cases with limbs fracture surgery were divided into three groups,100 cases in A group, oral administration with celecoxib 400mg 8h before surgery,200mg in the same day after surgery and 200mg twice a day during five days after surgery.and 90 cases in B group.Cases,oral administration with celecoxib 200mg in the same day after surgery and 200mg twice a day during five days after surgery.Cases in C group,administration without celecoxib.All the three groups did not restrict the requirements of intravenous analgesic pump,injected opioids after surgery.After surgery,pain intensity was measured with visual analog scale(VAS),and opium analgesic requirements, and the circumstances of vomit were observed.Results In the same day、the first day and second day after surgery,the VAS pain scores of A group were lower than those of other groups significantly(P〈0.05).However,in the third day,the fourth day,and the fifth day after surgery,there were no significant differences between the three groups in the VAS pain scores(〉P0.05).From the same day to the fifth day after surgery,the frequency of pethidine administration and vomit in the A group was lower than that in the other groups(P〈0.05).Conclusion Perioperative celecoxib oral administration can enhance the analgesic effect,reduce the opioids requirements and vomit.Preoperative celecoxib administration is valuable.
出处 《中国老年保健医学》 2011年第4期35-37,共3页 Chinese Journal of Geriatric Care
关键词 围手术期用药 术后疼痛 塞来昔布 Perioperative administration Postoperative pain Celecoxib
  • 相关文献

参考文献11

  • 1American Pain Society Quality Improvement Committee [ S ]. JA- MA. 1995, 1847 - 1880.
  • 2Joint Commission on Acchreditation of Healthcare Organizations [ S ]. Jt- Comm Perspect, 1999, 19(5) :6 -8.
  • 3Reuben SS, Ekman EF. The effect of cyclooxygenase-2 inhibition on an- algesia and spinal fusion [ J ]. J Bone Joint Surg Am, 2005,87 ( 3 ) : 536 - 542.
  • 4Aoki H, Satomoto M,Yamada S, et al. The effectiveness of perioperative intravenous flurbiprofen in minor ear,neck and nose surgery[ J]. Ma- sui ,2002,51 (8) :857 - 861.
  • 5NakayamaM, Ichinose H, Yamamoto SJ, et al. Perioperative intra-venous flurbiprofen reduces postoperative pain after abdominalhysterectomy [ J ]. Can J Anes ,2001,48 (3) :234 - 237.
  • 6施文,王永铭,程能能,陈斌艳,李端.上海地区非甾体抗炎药不良反应回顾与分析[J].中国临床药理学杂志,2004,20(2):144-148. 被引量:12
  • 7Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinaltoxicity with celecoxib vs nonsteroidal anti-inflammatory drugsfor osteoarthritis and rheumatoid arthritis: the CLASS study: arandomized controlled tri- al. Celecoxib Long-term Arthritis Safety Study [ J ]. JAMA, 2000,284 (10) : 1247 - 1255.
  • 8张立贤,王家双,彭亮,杨庆耿,王爱群,陈剑龄,舒慧芳.罗非昔布超前镇痛在无痛人流术中的应用[J].中国疼痛医学杂志,2005,11(1):22-24. 被引量:7
  • 9Buvanendran A, Kroin J S, Tuman K J, et al. Effects of perioperative ad-ministration of a selective cyclooxygenase 2 inhibitor on pain manage- ment and recovery of function after knee replacement: a randomized controlled trial[ J]. JAMA ,2003,290( 18)2411 -2418.
  • 10冯艺,鞠辉,杨拔贤,安海燕,周艳燕.术前口服罗非昔布对双膝关节置换术后疼痛和全身炎性反应的影响[J].中华外科杂志,2004,42(10):617-621. 被引量:11

二级参考文献31

  • 1徐德生,王国年,王玉.不同镇痛药物经静脉超前镇痛效应的观察[J].临床麻醉学杂志,2005,21(3):168-170. 被引量:62
  • 2[1]Lichtenstein D, Syngal S, Wife MM. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract[J]. Arthritis Rheum, 1995;38:1:5-18
  • 3[2]Bjamason I, Macpherson A, Somasundaram S, et al. Lower bowel toxicity of non-steroidal anti-inflammatory drugs[A]. Lewis A,Furst D. Non-steroidal Anti-Inflammatory Drugs. Mechanisms and Clinical Uses[M]. New York: NY, Marcel Dekker, 1994:145-157.
  • 4[3]James FF, Catherine AW, Daniel AB, et al. Nonsteroidal antiinflammatory drug associated gastropathy: in cidence and risk factor models[J]. Am JMed, 1991; 91:213-222.
  • 5Kang RY,Freire-Moar,Sigal E,et al.Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis.Br J Rheumatol,1996,35:711-718.
  • 6Andersson I,Tylman M,Bengtson JP,et al.Complement split products and pro-inflammatory cytokines in salvaged blood after hip and knee arthroplasty.Can J Anaesth,2001,48:251-255.
  • 7Hinz B,Brune K.Cyclooxygenase-2-10 years later.J Pharmacol Exp Ther,2002,300:367-375.
  • 8Wakai A,Wang JH,Winter DC.Tourniquet-induced systemic inflammatory response in extremity surgery.J Trauma,2001,51: 922-926.
  • 9McCormack K.Non-steroidal anti-inflammatory drugs and spinal nociceptive processing.Pain,1994,59: 9-43.
  • 10Warner TD,Giuliano F,Vojnovic I,et al.Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.Proc Natl Acad Sci,1999,96: 7563-7568.

共引文献55

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部